The onerous Health Insurance Tax included in the Affordable Care Act (ACA) was delayed thanks to bipartisan congressional action in 2015, and now new efforts to permanently repeal the anticipated 2018 tax are in the beginning stages.
Today, Reps. Kristi Noem (R-SD) and Kyrsten Sinema (D-AZ) introduced important legislation that repeals section 9010 of the ACA, a provision that levies a $100 billion tax on fully insured health plans—the primary health care option for many small and medium-sized manufacturers. Although officially a tax on health insurance plans, it is a “pass-through,” and the obligation is placed directly on those who are purchasing full-insured health plans.
The NAM has long supported repeal of this tax as it raises the cost of health care and provides an additional burden for employers who are also struggling to manage the overwhelming health care mandates and paperwork demands required by the ACA.
Manufacturers are proud to provide health insurance benefits for their employees, and in fact, 98 percent of manufacturers provide health insurance. Repeal of this tax will offer needed relief for smaller manufacturers who want to maintain a healthy workforce and continue doing right by their employees. However, challenges from the ACA are making it increasingly difficult to do so.
No one understands the frustrations of our health care system quite like manufacturers—rising health care and insurance costs are a top business challenge in our most recent Manufacturers’ Outlook Survey. The “Competing to Win” agenda and health care policy blueprint of the National Association of Manufacturers (NAM) calls on the next Congress and administration to find solutions that will successfully eliminate the costliest and most problematic aspects of the ACA. The NAM appreciates the leadership of Reps. Noem and Sinema and urges Congress not only to consider this important legislation but also include it in the upcoming budget reconciliation package, along with a repeal of the “Cadillac” and medical device taxes.
Latest posts by Robyn Boerstling (see all)
- Innovation Should not be a Scapegoat for Rising Health Care Costs - March 20, 2019
- Florida’s Proposed Prescription Drug Solution is Not an Actionable Solution - March 5, 2019
- Flawed Importation Proposals Continue to Offer False Promises - March 2, 2019